Dr Artur Schrörs, former head of Frankfurt’s Drugs Department, will speak at the Cannabis Health Symposium Frankfurt on 4 November about the need to distinguish recreational cannabis use from medically supervised treatment.
Schrörs said Germany’s legalisation of cannabis for recreational use had “transformed the societal debate”, but warned that it also risked “blurring” the distinction between recreational use and evidence-based cannabis therapy.
He said the result could be “persistent stigmatization”, leaving patients feeling “stigmatized rather than treated” and with “a sense of criminalization”.
“As a specialist group, our goal must be to ensure – through objective, science-based, and unbiased communication – that the medical aspect remains the focus, for the benefit of our patients,” he said.
Schrörs has worked across public health, addiction research and municipal health strategy, including as head of Frankfurt’s Drugs Department.
His work there included prevention programmes focused on digital and substance-related risks, as well as involvement in a research proposal on the controlled distribution of recreational cannabis.
He was also involved in the department’s medical cannabis work, which included a monthly telephone consultation for patients and a regional expert network.
His research focuses on municipal interventions, interdisciplinary cooperation and the use of scientific evidence in local policy.
Secure your place
The Cannabis Health Symposium Frankfurt takes place on 4 November 2026.
Secure your place at the Cannabis Health Symposium Frankfurt here.
